Developmental, vision, and hearing status in preterm infants receiving either a three day course of dexamethasone (Dex) or placebo
| Placebo (n=79) | Dex (n=80) | Odds ratio (95% CI) | |
| Normal development | 56 (71%) | 36 (45%) | 0.35 (0.19 to 0.65)5-150 |
| Abnormal development | 23 (29%) | 44 (55%) | 2.87 (1.53 to 5.38)5-150 |
| Mild abnormality | 12 (15%) | 26 (33%) | 2.57 (1.24 to 5.3)5-150 |
| Severe abnormality | 11 (14%) | 18 (22%) | 1.77 (0.79 to 3.95) |
| Vision Normal | 66 (85%) | 62 (78%) | 0.68 (0.31 to 1.49) |
| Glasses | 7 (9%) | 6 (8%) | 0.84 (0.27 to 2.59) |
| Strabismus | 4 (5%) | 8 (10%) | 2.02 (0.62 to 6.53) |
| Blind | 1 (1%) | 3 (4%) | 2.74 (0.38 to 19) |
| Deafness | 0 | 1 (1%) | 7.3 (0.14 to 99) |
↵5-150 Statistically significant difference.